SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: Czechsinthemail who wrote (445)12/16/1997 12:35:00 AM
From: Miljenko Zuanic  Respond to of 887
 
6-16 months ????

Is there a partial FDA approval???
Depo is approvable , but Cyt is not!!!

mz



To: Czechsinthemail who wrote (445)12/16/1997 8:53:00 AM
From: Tom D  Respond to of 887
 
Don't know. I figure a few months maximum.

Recall that the FDA was going to make a full decision in 1997 without ODAC, if ODAC's schedule was too tight to allow committee evaluation this year. Because of the survival-enhancing nature of the product, and the fact that it is being fast-tracked, I am guessing three months at the longest.

Tom D


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News